안구건조증에서 자가 혈소판 풍부 혈장이 안구표면에 미치는 영향: 임상 및 실험 분석
Effects of Platelet-rich Plasma on Ocular Surface in Patients with Dry Eye Syndrome: Clinico-experimental Analysis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
목적: 고삼투압성 눈물막에 의한 안구표면손상이 있는 환경에서 자가 혈소판 풍부 혈장이 어떠한 영향을 주는지 후향적 임상분석 및 실험 방법을 통하여 확인하고자 한다. 대상과 방법: 기존 치료에 효과가 없었던 중등도 안구건조증환자 80안을 대상으로 자가 혈소판 풍부 혈장 사용 전과 사용 후 1, 3, 6개월에 각각 시력, 안압, 눈물막파괴시간, 각결막 표면 형광염색점수, 안구표면질환지수를 비교 분석하였으며, 각막윤부상피세포 배양과 고삼투압 스트레스 실험 모델을 이용하여 안구표면세포의 염증성 인자의 변화를 분석하였다. 결과: 후향적 임상분석에서 자가 혈소판 풍부 혈장을 사용 후 64안(80%)에서 안구표면질환지수 설문조사에서 치료 전과 비교하여 증상 호전 및 증상 점수의 유의한 감소를 보였다. 객관적 지표인 눈물막파괴시간 및 각결막 표면 형광염색 점수 역시 각각 68안(85%), 72안(90%)에서 눈물막파괴시간의 유의한 증가 및 각결막 표면 형광염색점수의 유의한 감소를 보였다. 고삼투압하에서의 각막윤부상피세포는 혈소판 풍부 혈장을 추가한 경우 interleukin-1, tumor necrosis factor-α, metalloproteinase (MMP)-1, MMP-3과 같은 염증성 인자들이 감소하였다. 결론: 자가 혈소판 풍부 혈장의 사용으로 눈물막파괴시간, 각결막 표면 형광염색 점수, 안구표면질환지수에서 치료 전후 통계학적으로 의미 있는 호전을 보였으며, 안구건조증을 시뮬레이션한 고삼투압모델에서 항염증 효과가 입증되어 중등도 안구건조증에 자가혈소판풍부 혈장 투여가 효과적으로 사용될 수 있을 것으로 보인다.
Abstract
Purpose: To evaluate the effect of platelet rich plasma (PRP) on ocular surface damage caused by hyperosmotic conditions using retrospective clinical and experimental analyses. Methods: Eighty eyes of moderate dry eye syndrome patients who had no responses using conventional treatments were included in the study. Before and 1, 3, and 6 months after the use of autologous PRP, the visual acuity, intraocular pressure, tear break-up time (TBUT), ocular staining score (OSS), and ocular surface disease index (OSDI) were compared. The changes in inflammatory factors of ocular surface cells were analyzed using a corneo-limbal epithelial cell culture and a hyperosmotic stress experimental model. Results: Using retrospective clinical analyses, in 64 eyes (80%) after the use of autologous PRP, the symptom scores and symptoms were significantly reduced in the OSDI questionnaire when compared with the symptom scores and symptoms before treatment. The TBUT and OSS, which were objective indicators showed a significant increase of TBUT and significant decrease of OSS in 68 eyes (85%) and 72 eyes (90%), respectively. The expression of inflammatory factors such as interleukin-1, tumor necrosis factor-α, metalloproteinase (MMP)-1, and MMP-3 decreased in corneo-limbal epithelial cells under hyperosmotic conditions when PRP was added. Conclusions: The use of autologous PRP showed significant improvement before and after treatment in the TBUT, OSS, symptom scores and symptoms, and OSDI. In addition, anti-inflammatory effects were demonstrated in hyperosmotic models simulating dry eye syndrome. Therefore, autologous PRP could be used effectively for the treatment of moderate dry eye syndrome.
참고문헌 (44)
- Miljanović B, "Impact of dry eye syndrome on vision-related quality of life", Am J Ophthalmol, 143, pp.409~415 (2007)
- Tong L, "Impact of symptomatic dry eye on vision-related daily activities. the Singapore Malay Eye Study", Eye, 24, pp.1486~1491 (2010)
- Gupta A, "Transforming growth factor beta-1and beta-2 in human tear fluid", Curr Eye Res, 15, pp.605~614 (1996)
- Nishida T, "Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea", J Cell Physiol, 169, pp.159~166 (1996)
- Watanabe K, "Stimulatory effects of fibronectin and EGF on migration of corneal epithelial cells", Invest Ophthalmol Vis Sci, 28, pp.205~211 (1987)
- Barton K, "Cytokines and tear function in ocular surface disease", Adv Exp Med Biol, 438, pp.461~469 (1998)
- Fukuda M, "Fibronectin in the tear film", Invest Ophthalmol Vis Sci, 37, pp.459~467 (1996)
- Lopez Bernal D, "Artificial tear composition and promotion of recovery of the damaged corneal epithelium", Cornea, 12, pp.115~120 (1993)
- Pancholi S, "The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes", Graefes Arch Clin Exp Ophthalmol, 236, pp.1~8 (1998)
- Tsubota K, "Decreased reflex tearing is associated with lymphocytic infiltration in lacrimal glands", J Rheumatol, 23, pp.313~320 (1996)
- Wilson SE, "Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding", Invest Ophthalmol Vis Sci, 40, pp.2185~2190 (1999)
- Hartwig D, "Epitheliotrophic capacity of a growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects?", Transfusion, 44, pp.1724~1731 (2004)
- Knighton DR, "Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet derived wound healing formula", Surg Gynecol Obstet, 170, pp.56~59 (1990)
- Lynch SE, "Growth factors in wound healing. Single and synergistic effects in partial thickness porcine skin wounds", J Clin Invest, 84, pp.640~646 (1989)
- Alio JL, "Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers", Ophthalmology, 114, pp.1286~1293 (2007)
- Alio JL, "Treatment of ocular surface syndrome after LASIK with autologous platelet-rich plasma", J Refract Surg, 23, pp.617~619 (2007)
- Alio JL, "Symptomatic dry eye treatment with autologous platelet-rich plasma", Ophthalmic Res, 39, pp.124~129 (2007)
- Kim KM, "Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis", Jpn J Ophthalmol, 56, pp.544~550 (2012)
- 이준헌, "Autologous Platelet-rich Plasma Eye Drops in the Treatment of Recurrent Corneal Erosions", Korean Journal of Ophthalmology, 30(2), pp.101~107 (2016), 대한안과학회
- Nelson JD, "TFOS DEWS II introduction", Ocul Surf, 15, pp.269~275 (2017)
- Tsubota K, "Treatment of persistent epithelial defect by autologous serum application", Ophthalmology, 106, pp.1984~1989 (1999)
- Goto E, "Treatment of superior limbic keratoconjunctivitis by application of autologous serum", Cornea, 20, pp.807~810 (2001)
- del Castillo JM, "Treatment of recurrent corneal erosions using autologous serum", Cornea, 21, pp.781~783 (2002)
- Tananuvat N, "Controlled study of the use of autologous serum in dry eye patients", Cornea, 20, pp.802~806 (2001)
- Ogawa Y, "Autologous serum eyedrops for the treatment of severe dry eye in patients with chronic graftversus-host disease", Bone Marrow Transplant, 31, pp.579~583 (2003)
- Tsubota K, "Treatment of dry eye by autologous serum application in Sjögren's syndrome", Br J Ophthalmol, 83, pp.390~395 (1999)
- Anitua E, "Autologous platelets as a source of proteins for healing and tissue regeneration", Thromb Haemost, 91, pp.4~15 (2004)
- Stassen JM, "The hemostatic system", Curr Med Chem, 11, pp.2245~2260 (2004)
- Klinger MH, "Role of blood platelets in infection and inflammation", J Interferon Cytokine Res, 22, pp.913~922 (2002)
- Ho PC, "Kinetics of corneal epithelial regeneration and epidermal growth factor", Invest Ophthalmol, 13, pp.804~809 (1974)
- Gönül B, "Effect of EGF on the corneal wound healing of alloxan diabetic mice", Exp Eye Res, 54, pp.519~524 (1992)
- Rodeck U, "EGF-R dependent regulation of keratinocyte survival", J Cell Sci, 110(Pt 2), pp.113~132 (1997)
- Yashino Y, "Production and secretion of transforming growth factor beta(TGF-β)by the human lacrimal gland", Curr Eye Res, 15, pp.615~624 (1996)
- Sammartino G, "Use of autologous platelet-rich plasma(PRP)in periodontal defect treatment after extraction of impacted mandibular third molars", J Oral Maxillofac Surg, 63, pp.766~770 (2006)
- Choi BH, "Effect of platelet-rich plasma on bone regeneration in autogenous bone graft", Int J Oral Maxillofac Surg, 33, pp.56~59 (2004)
- Englert SJ, "Autologous platelet gel applications during cardiovascular surgery : effect on wound healing", J Extra Corpor Technol, 37, pp.148~152 (2005)
- Man D, "The use of autologous platelet-rich plasma(platelet gel)and autologous platelet-poor plasma(fibrin glue)in cosmetic surgery", Plast Reconstr Surg, 107, pp.229~237 (2001)
- Bhanot S, "Current applications of platelet gels in facial plastic surgery", Facial Plast Surg, 18, pp.27~33 (2002)
- Li DQ, "JNK and ERK MAP kinases meidate induction of IL-1β, TNF-α and IL-8 following hyperosmolar stress in human limbal epithelial cells", Exp Eye Res, 82, pp.588~596 (2006)
- Li DQ, "Stimulation of matrix metallopreteinases by hyperosmolarity via a JNK pathwasy in human corneal epithelial cells", Invest Ophthalmol Vis Sci, 45, pp.4302~4311 (2004)
- Zeigler ME, "Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes", J. Cell Physiol, 180, pp.271~284 (1999)
- Cho A, "Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells", Arterioscler Thromb Vasc Biol, 20, pp.2527~2532 (2000)
- Hayashida T, "Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGFbeta dependent responses in human mesangial cells", FASEB J, 17, pp.1576~1578 (2003)
- Gospodarowicz D, "The angiogenic activity of the fibroblast and epidermal growth factor", Exp Eye Res, 28, pp.501~514 (1979)
